ArticleCommunications biology2025
Bacillus subtilis TO-A suppresses the age-related decline in locomotion in Caenorhabditis elegans.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research on the role of probiotics in maintaining locomotor function in aged Caenorhabditis elegans is limited. Therefore, we investigated whether a probiotic strain, Bacillus subtilis TO-A (BSTOA), which extends the lifespan of worms can prevent age-related declines in the locomotor functions of aged worms. This study revealed that aged worms fed BSTOA (BSTOA_day13) maintained better locomotor function than those fed Escherichia coli OP50 (OP50_day13). BSTOA_day13 exhibited better activity than OP50_day13 in maintaining actin structure during age-related changes in body wall muscles. Notably, the expression levels of oxidative stress-related genes fluctuated in BSTOA_day13; these worms also displayed high survival rates based on the paraquat assay. An examination of the locomotor function of aged gpx-7 mutants revealed that even worms fed BSTOA had a reduced thrashing rate. Therefore, consuming BSTOA may prevent the decline in age-related locomotor functions, such as symptoms of sarcopenia in humans, by inhibiting the decrease in gpx-7 expression in aged worms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.